
Many Peaks Minerals appoints Jamie Byrde as CFO
- Many Peaks Minerals appointed Jamie Byrde to bolster its finance and governance capabilities as the company advances its gold exploration portfolio in Côte d'Ivoire.
- The company's share price remained unchanged at $0.81 following the executive management update.
- The appointment aims to support ongoing growth, statutory reporting, and corporate governance as the explorer moves towards project delivery and expanded drilling.
Many Peaks Minerals (ASX:MPK) has appointed experienced chartered accountant Jamie Byrde as CFO to strengthen its executive finance and governance capabilities as it advances its gold exploration portfolio in Côte d'Ivoire.
The corporate update follows recent operational progress at the company's West African projects, where exploration activities continue to scale towards scoping studies and resource evaluation.
"Jamie’s appointment comes at an important time for Many Peaks as we move towards delivery of our scoping study and ramp up drilling at Ferke," said Many Peaks Minerals Managing Director Travis Schwertfeger.
Byrde brings over 20 years of resource industry experience, including previous roles managing capital raisings of approximately $100 million and leading cross-border acquisitions across international jurisdictions.
The executive addition provides key financial structure as the company advances exploration activities across its West African gold assets.
Following the announcement, the Many Peaks Minerals share price was unchanged at $0.84.
Many Peaks Minerals is an Australian mineral exploration company primarily focused on advancing gold and copper projects in West Africa and Australia.
The explorer continues to progress key exploration targets, including its flagship Ferke gold project in Côte d'Ivoire.
Frequently asked questions
More from Australia
Titanium Sands secures $500,000 Sri Lankan funding
WIN Metals expands Butchers Creek gold tenure package
Forte Energy enters South American oil exploration agreement
Pathkey.AI validates Chipforge platform through independent testing
Arovella Therapeutics names acting CEO
Ingenia Communities rejects new Warburg Pincus buyback offer
